bioRxiv · 10.1101/2020.10.28.358614
Induced pulmonary comorbidities render CD-1 mice sensitive to SARS-CoV-2
Abstract
Severe manifestations of COVID-19 are mostly restricted to people with comorbidities. Here we report that induced mild pulmonary morbidities render SARS-CoV-2-refractive CD-1 mice to be susceptible to this virus. Specifically, SARS-CoV-2 infection after application of low-doses of the acute-lung-injury stimulants bleomycin or ricin caused a severe disease in CD-1 mice, manifested by sustained body weight loss and mortality rates of >50%. Further studies revealed markedly higher levels of viral RNA in the lungs, heart and serum of low-dose-ricin pretreated, as compared to non-pretreated mice. Notably, the deleterious effects of SARS-CoV-2 infection were effectively alleviated by passive transfer of polyclonal or monoclonal antibodies generated against SARS-CoV-2 RBD. Thus, viral cell entry in the sensitized mice seems to involve viral RBD binding, albeit by a mechanism other than the canonical ACE2-mediated uptake route. In summary, we present a novel mice-based animal model for the study of comorbidity-dependent severe COVID-19.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Falach, R., Bar-On, L., Lazar, S., Kadar, T., Mazor, O., Aftalion, M., Gur, D., Shifman, O., Israeli, O., Cohen-Gihon, I., Zaida, G., Gutman, H., Evgy, Y., Vagima, Y., Makdasi, E., Stein, D., Rosenfeld, R., Alcalay, R., Zahavy, E., Levy, H., Glinert, I., Ben-Shmuel, A., Israely, T., Melamed, S., Politi, B., Achdout, H., Yitzhaky, S., Kronman, C., Sabo, T.. 2020-10-28. Induced pulmonary comorbidities render CD-1 mice sensitive to SARS-CoV-2. https://doi.org/10.1101/2020.10.28.358614
Cite the original work for its findings. Save a collection to share your selection of sources.